Hamilton researchers will attempt to take the blinders off of white blood cells so the immune system can spot cancer and fight it.
The intention is for their discovery to be turned into new cancer drugs developed by biotechnology company Triumvira Immunologics opening up in McMaster Innovation Park.
The partnership is getting $2.3 million from Genome Canada as part of $8.1 million in federal funding for five new projects expected to be announced Friday at McMaster University. An additional $16.4 million is going to the projects from provincial governments, businesses and research partners.
